Conference call to be held on Tuesday, August 20, 2024 , at 10:00 a.m. U.
S. EDT REHOVOT, Israel , Aug. 6, 2024 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN ), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today announced that it will report financial statements for the second quarter of 2024 on Tuesday, August 20, 2024 , before the opening of the U.
S. financial markets. The Company will then host a conference call and webcast to discuss its financial statements and corporate updates on August 20 at 10:00 a.
m. Eastern Daylight Time. Conference call information To participate in the conference call, please use the dial-in information below: U.
S. investors: 1-877-407-9716 Investors outside of the U.S.
: 1-201-493-6779 Israel investors: 1-809-406-247 Conference ID: 13746304 Note, you can avoid long wait times for the operator by using the Call meTM feature and clicking the link below 15 minutes prior to the scheduled call start time: https://callme.viavid.com/viavid/?callme=true&passcode=13728588&h=true&info=company-email&r=true&B=6 Webcast information A live webcast will also be available in listen-only mode and can be accessed here or via the link to be posted on the News & Events section of the CollPlant Investor relations website.
A replay of the webcast will be available following the conclusion of the live broadcast and will be .